Alkermes plc Profile Avatar - Palmy Investing

Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products …
Biotechnology
IE, Dublin [HQ]
ALKS/Financial Reporting

Income Statements

14 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Revenue
178.00 186.00 389.00 575.00 618.00 628.00 745.00 903.00 1,094.00 1,170.00 1,038.00 1,173.00 1,111.00 1,663.00
EPS
-0.42 -0.48 -0.99 0.19 -0.21 -1.52 -1.38 -1.03 -0.90 -1.25 -0.70 -0.30 -0.97 2.14
Profit
128.00 134.00 262.00 265.00 170.00 144.00 226.00 335.00 492.00 477.00 465.00 569.00 893.00 1,374.00
Pre Tax
-44.00 -46.00 -114.00 35.00 -14.00 -224.00 -214.00 -143.00 -126.00 -197.00 -96.00 -39.00 -167.00 421.00
ETR
11.35 2.05 0.62 29.51 -114.28 -1.41 2.77 -10.24 -9.72 0.22 -14.84 -22.55 5.40 -23.16
Net
-39.00 -45.00 -113.00 24.00 -30.00 -227.00 -208.00 -157.00 -139.00 -196.00 -110.00 -48.00 -158.00 355.00
EBITDA
-38.00 -42.00 6.00 173.00 -29.00 -163.00 -146.00 -90.00 -26.00 -106.00 -52.00 11.00 -96.00 486.00
Operating Income
-43.00 -45.00 -88.00 81.00 -87.00 -224.00 -208.00 -147.00 -99.00 -162.00 -112.00 -26.00 -142.00 414.00
Interest Income
4.00 2.00 1.00 - - 1.00 3.00 3.00 4.00 9.00 13.00 6.00 2.00 7.00 30.00
Loss
-221.00 -232.00 -478.00 -478.00 -705.00 -852.00 -954.00 -1,051.00 -1,193.00 -1,333.00 -1,151.00 -1,203.00 -1,254.00 -1,249.00
Cost of Revenue
-49.00 -52.00 -127.00 -310.00 -447.00 -483.00 -519.00 -567.00 -601.00 -693.00 -572.00 -603.00 -218.00 -288.00
Operating Expenses
-171.00 -180.00 -350.00 -167.00 -258.00 -369.00 -435.00 -483.00 -591.00 -639.00 -578.00 -599.00 -1,035.00 -960.00
Depreciation and Amortization
-25.00 -8.00 -93.00 -73.00 -98.00 -85.00 -94.00 -98.00 -103.00 -80.00 -81.00 -78.00 -77.00 -72.00
Interest Expenses
-5.00 -3.00 -28.00 -48.00 -13.00 -13.00 -14.00 -12.00 -15.00 -13.00 -8.00 -11.00 -13.00 -23.00
Other Expenses
- - - - - - -13.00 -84.00 -10.00 -5.00 -11.00 -27.00 -34.00 -15.00 -12.00 -25.00 -7.00
WA Shares Outstanding
94.00 95.00 114.00 131.00 143.00 149.00 151.00 153.00 155.00 157.00 158.00 160.00 163.00 166.00
End of ALKS's Analysis
CIK: 1520262 CUSIP: G01767105 ISIN: IE00B56GVS15 LEI: - UEI: -
Secondary Listings
ALKS has no secondary listings inside our databases.